Biobase
Biobase is a German bioinformatics company that develops and licenses manually curated molecular biology databases—including TRANSFAC, TRANSPATH, BRENDA, and the BioKnowledge Library—on a subscription basis to academic, pharmaceutical, and biotechnology research customers globally.
- Company typePrivate
- Founded1997
- HeadquartersGermering, Germany
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What Biobase does
Biobase (legal entity Brüller GmbH) is a German bioinformatics company founded in 1997 as a spin-off from the German Research Center for Biotechnology (GBF) in Braunschweig. The company develops, curates, and licenses manually curated molecular biology databases and integrated software platforms for academic and pharmaceutical research, with proprietary products including TRANSFAC (eukaryotic transcription factors), TRANSPATH (signal transduction pathways), BRENDA (enzymology with 80,000+ entries), and the integrated BioKnowledge Library (BKL). Data assets span transcription factors, enzymes, promoter sequences, pathways, and proteomes across yeast, worm, human, and rodent species, supplemented by tools such as MATCH, ExPlain, Pathway Builder, and Array Analyzer for gene regulation and pathway analysis.
Biobase operates a B2B subscription-based licensing model, charging institutional annual fees via quote-based pricing to academic institutions, pharmaceutical companies, and biotechnology firms globally. Distribution is conducted through three wholly-owned subsidiaries in the United States (Beverly, Massachusetts), India, and Japan, alongside direct sales from its German headquarters. In addition to proprietary databases, Biobase distributes selected third-party bioinformatics products (QIAGEN-integrated databases, CLC Genomics Workbench, HGMD, QCI Interpret) and offers Knowledge Process Outsourcing services for gene expression content.
The company employs approximately 150 staff and traces its primary assets to foundational acquisitions: exclusive worldwide BRENDA marketing rights secured in 2003 and the Incyte database assets acquired in 2005 that seeded the Proteome BKL. Revenue figures are not publicly disclosed, and the company has remained privately held under Brüller GmbH since its 1999 acquisition by MBG Hannover.
Biobase firmographics
Firmographics- Name
- Biobase
- Legal name
- Brüller GmbH
- Website
- https://biobase.de
- Company type
- Private
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Biobase is a German bioinformatics company that develops and licenses manually curated molecular biology databases—including TRANSFAC, TRANSPATH, BRENDA, and the BioKnowledge Library—on a subscription basis to academic, pharmaceutical, and biotechnology research customers globally.
- Ownership category
- akta.pro rank
Biobase industry classification
Industry- Product category
- Bioinformatics Databases and Software
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)
- akta.pro secondary industry
- Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI)
Keywords
Where Biobase is headquartered
LocationHeadquarters
- HQ city
- Germering
- HQ country
- Germany
- HQ region
- Europe
Offices3 records
Markets served
Biobase business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Database Licensing: Biobase licenses its biological databases including TRANSFAC, TRANSPATH, BRENDA, and the BioKnowledge Library to research institutions, pharmaceutical companies, and academic researchers. Revenue is generated through subscription-based access to curated molecular biology databases and software platforms.
- Software Platform Access: Access to proprietary software tools including BKL Search, MATCH-Tool, Matrix-Tool, Array Analyzer, Pathway Builder, and ExPlain system for data analysis and interpretation.
- Third-Party Product Distribution: Distribution of third-party bioinformatics products including IPA, CLC Genomics Workbench, HGMD, and various QCI Interpret products. Revenue from reselling and distributing partner-developed databases.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Subscription-based database access |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Biobase product offering
Product offeringCore offering
Biobase develops, curates, and licenses manually curated molecular biology databases and bioinformatics software platforms for life sciences research and pharmaceutical R&D. Its core offering is the BioKnowledge Library (BKL), which integrates databases covering eukaryotic transcription factors (TRANSFAC), signal transduction pathways (TRANSPATH), enzymes (BRENDA with 80,000+ entries), and species-specific proteomes, delivered alongside proprietary analysis tools such as ExPlain, MATCH, Pathway Builder, and Array Analyzer. The company also distributes third-party bioinformatics products and offers Knowledge Process Outsourcing services focused on gene expression content.
Product overview
Biobase offers a platform-plus-modules architecture centered on the BIOBASE Knowledge Library (BKL), which combines two main modules: the TRANSFAC Suite for eukaryotic gene regulation analysis and the PROTEOME module for protein data. The platform includes analysis tools (MATCH, FMatch, COMPOSITE MODEL, MATRIX, ExPlain, Array Analyzer, Pathway Builder, BKL Search, BKL Pathfinder, Network Analysis, and BKT). Core proprietary databases include TRANSFAC (transcription factors), TRANSPATH (signal pathways), BRENDA (enzymes with 80,000+ entries), TRANSCompel, TRANSPro, PathoDB, YPD, HumanPSD, PombePD, WormPD, and GPCR-PD, plus BRENDA sub-products (BTO, FRENDA, AMENDA, DRENDA, KENDA). Biobase distributes selected third-party products and offers Knowledge Process Outsourcing services for gene expression content.
Differentiator
Problem solved
Functional benefit
Brands
- TRANSFAC: Comprehensive database of eukaryotic transcription factors, their experimentally determined DNA binding sites, and regulated genes.
- TRANSPATH
- BRENDA
- Proteome BKL
Products and services
- BIOBASE Knowledge Library (BKL) A comprehensive software platform combining proteomics and genomics databases, enabling researchers to cross-reference their results with existing data and access extensive expert-curated background information; targets academic and pharmaceutical researchers in molecular biology.
- TRANSFAC A manually curated database containing comprehensive data on eukaryotic transcription factors, their experimentally determined DNA-binding sites, and the genes they regulate; serves as a reference work for eukaryotic gene regulation analysis by academic and pharmaceutical researchers.
- TRANSPATH A complete molecular biology database system focused on signal pathways in gene regulation, providing extended analysis capabilities for identifying signaling pathways and building regulatory networks from molecules, genes, and reactions; targets life sciences researchers.
- BRENDA (Braunschweig Enzyme Database) One of the world's largest online biochemistry databases containing molecular biological and biochemical data on over 80,000 enzymes and their metabolic pathways extracted from scientific publications; targets biochemists, enzymologists, and systems biology researchers.
- Knowledge Process Outsourcing Services providing specific content and analyses on gene expression topics; targets research institutions and pharmaceutical companies requiring outsourced curation and analysis expertise.
- Third-Party Bioinformatics Product Distribution Reselling and distribution of partner-developed bioinformatics databases and software (IPA, CLC Genomics Workbench, HGMD, QCI Interpret); targets researchers requiring complementary tools alongside Biobase proprietary products.
Companies that use Biobase
Customer profileSegments3 records
Ideal customer profiles3 records
Biobase technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Biobase partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- University of TokyocoreBiobase maintains research partnerships with leading universities including the University of Tokyo for collaborative research in bioinformatics and molecular biology.
- Fraunhofer Institut Toxikologie und Experimentelle MedizincoreResearch partnership with Fraunhofer Institute for Toxicology and Experimental Medicine for collaborative scientific projects.
- Sysco Project ConsortiumminorResearch consortium combining experimental and simulation approaches to study intracellular processes in parasite infections.
- TRANSISTOR Project ConsortiumminorResearch project focused on regulatory processes in plants, involving collaborative research with academic partners.
- Helmholtz Association / German Research Center for Biotechnology (GBF)coreBiobase was founded in 1997 as a spin-off from the German Research Center for Biotechnology (now part of Helmholtz Association). Maintains ongoing relationships with the research institution.
Scale indicators6 records
Recent moves8 records
Expansion highlights5 records
Biobase competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Biobase financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biobase leadership team
Management profileNumber of profiles
Profiles3 records
Biobase subsidiaries and ownership
Company hierarchySubsidiaries3 records
Biobase funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biobase M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biobase
What does Biobase do?
Biobase develops, curates, and licenses manually curated molecular biology databases and bioinformatics software platforms for life sciences research and pharmaceutical R&D. Its core offering is the BioKnowledge Library (BKL), which integrates databases covering eukaryotic transcription factors (TRANSFAC), signal transduction pathways (TRANSPATH), enzymes (BRENDA with 80,000+ entries), and species-specific proteomes, delivered alongside proprietary analysis tools such as ExPlain, MATCH, Pathway Builder, and Array Analyzer. The company also distributes third-party bioinformatics products and offers Knowledge Process Outsourcing services focused on gene expression content.
Is Biobase a public or private company?
Biobase is a private company. It is classified as private equity controlled and is currently operating.
When was Biobase founded?
Biobase was founded in 1997. It employs 101 to 250 people.
Where is Biobase based?
Biobase is headquartered in Germering, Germany, in the Europe region.
How does Biobase make money?
Three revenue lines are on record. Database Licensing is the primary driver. The others are software Platform Access and third-Party Product Distribution.
Does Biobase have an API?
No public API is recorded for Biobase.
What industry is Biobase in?
Biobase's product category is Bioinformatics Databases and Software. Its primary akta.pro industry code is HLAGAJAD, Bioinformatics & Multi-omics Analysis Software, with a secondary code of HLAGANAI, Bioinformatics, Multi-Omics Data Analysis & Interpretation Services. Its NAICS code is 54171 and its SIC code is 8731.